Form 8-K - Current report:
SEC Accession No. 0001593034-24-000006
Filing Date
2024-03-06
Accepted
2024-03-06 16:54:16
Documents
17
Period of Report
2024-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K endp-20240306.htm   iXBRL 8-K 37687
2 EX-99.1 a20231231ex991earningsrele.htm EX-99.1 851202
7 endoelogo.jpg GRAPHIC 186772
  Complete submission text file 0001593034-24-000006.txt   1303985

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT endp-20240306.xsd EX-101.SCH 2218
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT endp-20240306_def.xml EX-101.DEF 3748
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT endp-20240306_lab.xml EX-101.LAB 22636
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT endp-20240306_pre.xml EX-101.PRE 13060
18 EXTRACTED XBRL INSTANCE DOCUMENT endp-20240306_htm.xml XML 2467
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

EIN.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 24726717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)